# Evaluation of Serum Zinc Status in Patients With Neurologic Impairment Under Controlled Enteral Nutrition

**Authors:** Naoki Hashizume, Hirotomo Nakahara, Takato Aikoh, Hiroki Yoshida, Tomohiro Kurahachi, Saki Sakamoto, Daisuke Masui, Yoshinori Koga, Koshiro Sugita, Tatsuru Kaji

PMC · DOI: 10.7759/cureus.98266 · Cureus · 2025-12-01

## TL;DR

This study found that many patients with neurological impairments on controlled nutrition still have low zinc levels, even when they meet recommended intake levels.

## Contribution

The study reveals zinc deficiency in neurologically impaired patients despite controlled nutrition, suggesting the need for individualized monitoring.

## Key findings

- 25.8% of patients with neurological impairments had serum zinc deficiency.
- Zinc intake was significantly lower in patients with low zinc levels.
- Serum albumin and daily zinc intake were independently associated with serum zinc levels.

## Abstract

Background: Patients with neurologic impairment (NI) often require long-term enteral nutrition. Zinc plays a vital role in neurological and immune function, yet data on zinc intake and status in NI patients remain limited. This study aimed to evaluate whether serum zinc concentrations reflect standardized daily zinc intake in patients with NI receiving fixed-content enteral formulas (EFs) and to identify factors associated with serum zinc levels.

Methods: This retrospective study included bedridden NI patients aged ≥16 years who received EFs via nasogastric or gastrostomy feeding. Clinical parameters, serum biochemical markers, and daily nutrient intake were assessed. Patients were stratified by serum zinc levels (<60 μg/dL or ≥60 μg/dL). Univariate and multivariate linear regression analyses were performed to identify factors independently associated with serum zinc concentrations.

Results: Of 31 patients analyzed, 8 (25.8%) exhibited serum zinc deficiency. Zinc intake was significantly lower in the low zinc group compared to the normal zinc group (9.2 vs. 13.5 mg/day, p = 0.0157). Notably, zinc deficiency was observed even in individuals whose zinc intake exceeded the Estimated Average Requirement (EAR) or Recommended Dietary Allowance (RDA). In regression analyses, both daily zinc intake (β = 1.28, p = 0.0273) and serum albumin (β = 14.87, p = 0.0407) were independently associated with serum zinc levels.

Conclusions: Despite controlled enteral nutrition, a substantial proportion of patients with NI exhibited zinc deficiency. Although limited by a small sample size, these findings highlight the importance of individualized monitoring and potential supplementation beyond standardized intake levels.

## Linked entities

- **Chemicals:** zinc (PubChem CID 23994)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** zinc deficiency (MESH:C564286), NI (MESH:D009422)
- **Chemicals:** Zinc (MESH:D015032)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12756684/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12756684/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12756684/full.md

---
Source: https://tomesphere.com/paper/PMC12756684